Abbisko, AstraZeneca Team Up on Lung Cancer Drug Combo After China Trial Clearance

Abbisko Therapeutics Co. Ltd. on Wednesday entered into a strategic collaboration with AstraZeneca Plc to jointly develop a novel combination therapy for patients with EGFR-mutated and PD-L1 positive ...